Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors

PHASE4UnknownINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Non Functioning Pancreatic Endocrine Tumor
Interventions
BIOLOGICAL

Chromogranin A

The plasma level of chromogranin A (CgA) was measured in enrolled patients who was diagnosed as PNET in preoperative condition.After surgical resection, the CgA level was only measured in the the patient with PNET. In the PNET group, the CgA level was regularly checked in a 3, 6, 12, and 24 months after surgical resection.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Asan Medical Center

OTHER